ArticleJournal for immunotherapy of cancer2025

Tumor-intrinsic TTLL12 drives resistance to cancer immunotherapy via modulating myeloid-derived suppressor cells.

Dong-Wen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.